Latest news with #PaulduSaillant
Fashion Network
4 days ago
- Business
- Fashion Network
Essilorluxottica to buy Optegra eyecare clinics
Essilorluxottica has entered an agreement to buy Optegra ophthalmic clinics from MidEuropa, as the Franco-Italian eyewear group aims to expand in the medical technology industry, the companies said on Friday. Financial details of the transaction, which is expected to close later this year, were not disclosed. The Optegra group operates a network of over 70 eye hospitals and diagnostic facilities in the UK, Czech Republic, Poland, Slovakia and the Netherlands under the Optegra, Lexum and Iris brands. It serves both publicly reimbursed and private-pay patients, providing treatments and vision correction procedures such as cataract surgery, age-related macular degeneration and glaucoma treatments, refractive lens replacement and laser eye surgery. "With the acquisition of Optegra, we are stepping into a new frontier – one where comprehensive eyecare, advanced diagnostics, therapeutic interventions and surgical treatments come together in one seamless platform", Essilorluxottica CEO Francesco Milleri and deputy CEO Paul du Saillant said in a statement. Essilorluxottica was advised by Rothschild for the transaction. It is aiming to expand beyond its traditional lenses and sunglasses products, into complementary sectors characterised by a strong technological component, such as Ray-Ban Meta smart glasses or hearing aids applied to glasses.
Fashion Network
4 days ago
- Business
- Fashion Network
Essilorluxottica to buy Optegra eyecare clinics
Essilorluxottica has entered an agreement to buy Optegra ophthalmic clinics from MidEuropa, as the Franco-Italian eyewear group aims to expand in the medical technology industry, the companies said on Friday. Financial details of the transaction, which is expected to close later this year, were not disclosed. The Optegra group operates a network of over 70 eye hospitals and diagnostic facilities in the UK, Czech Republic, Poland, Slovakia and the Netherlands under the Optegra, Lexum and Iris brands. It serves both publicly reimbursed and private-pay patients, providing treatments and vision correction procedures such as cataract surgery, age-related macular degeneration and glaucoma treatments, refractive lens replacement and laser eye surgery. "With the acquisition of Optegra, we are stepping into a new frontier – one where comprehensive eyecare, advanced diagnostics, therapeutic interventions and surgical treatments come together in one seamless platform", Essilorluxottica CEO Francesco Milleri and deputy CEO Paul du Saillant said in a statement. Essilorluxottica was advised by Rothschild for the transaction. It is aiming to expand beyond its traditional lenses and sunglasses products, into complementary sectors characterised by a strong technological component, such as Ray-Ban Meta smart glasses or hearing aids applied to glasses.
Yahoo
24-04-2025
- Business
- Yahoo
EssilorLuxottica reports Q1 revenue EUR 6.85B, up 7.3% at CER
Francesco Milleri, Chairman and CEO, and Paul du Saillant, Deputy CEO at EssilorLuxottica (ESLOY) commented: 'In the first quarter, we successfully maintained strong momentum, with all regions and businesses contributing to steady growth — each playing an integral role in advancing our journey in the wearables and med-tech space. From the new six-year clinical data confirming long-term efficacy of Stellest in slowing myopia progression to the transformative Nuance Audio launch marking an entirely new category in the U.S., Italy and France, we are making significant strides toward our strategic goals. Our brands are showing the power of relevance like never before, including Ray-Ban Meta's extraordinary trajectory, Oakley celebrating its 50th year of being the world's favorite sport performance brand and Oliver Peoples extending its partnership with legend Roger Federer. At the heart of this momentum are our 200,000 dedicated colleagues, whose commitment and passion fuel our continued success. Their growing involvement as shareholders stands a powerful testament to their trust in our Company and the values that define us. In a time of uncertainty, we advance with purpose, ambition and confidence in the future we are building together'. Discover outperforming stocks and invest smarter with Top Smart Score Stocks. Filter, analyze, and streamline your search for investment opportunities using Tipranks' Stock Screener. Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>> See Insiders' Hot Stocks on TipRanks >> Read More on ESLOY: Disclaimer & DisclosureReport an Issue EssilorLuxottica price target lowered to EUR 270 from EUR 280 at JPMorgan EssilorLuxottica price target raised to EUR 272 from EUR 266 at UBS Sign in to access your portfolio
Reuters
13-02-2025
- Business
- Reuters
EssilorLuxottica operating profit rose 9.4% last year
MILAN, Feb 12 (Reuters) - Eyewear maker EssilorLuxottica ( opens new tab said on Wednesday its adjusted operating profit rose 9.4% last year, to 4.4 billion euros ($4.6 billion), broadly in line with analysts' expectations. Revenues at the group, whose brands include Ray-Ban, rose 9.2% at constant exchange rates in the fourth quarter, accelerating compared the third quarter and bringing the total revenues for the year to 26.5 billion euros, a touch above a 26.4 billion euros analysts forecast according to LSEG data. "We celebrate... our fourth consecutive year of top line growth on track with our targets including a strong acceleration in the fourth quarter, with all regions and businesses contributing to our momentum," said Francesco Milleri, Chairman and CEO, and Paul du Saillant, Deputy CEO. The managers added that the Franco-Italian group remains on track with its long-term targets. The company confirmed its target of mid-single-digit annual revenue growth from 2022 to 2026 at constant exchange rates, noting it targets a range of 27-28 billion euros by the end of the period. It also confirmed it expects to achieve an adjusted operating profit equal to 19-20% of revenues by 2026, from 17% at the end of last year. Although the company still generates most of its revenues from the sale of frames and lenses, it is looking to expand into new sectors such as medical and high-tech. The group said that it had sold 2 million units of Ray-Ban Meta smartglasses since their launch, with a strong acceleration in 2024. ($1 = 0.9638 euros)
